Company Announcements

Share Repurchase Programme - Third Tranche

Source: RNS
RNS Number : 4202H
Kingfisher PLC
24 November 2022




Share repurchase programme - Third Tranche


24 November 2022: Kingfisher plc (the "Company" or "Kingfisher") announces that it has instructed BNP Paribas Exane ("BNP Paribas Exane") in relation to an irrevocable non-discretionary programme to purchase its shares for cancellation, during the period which commences today and ends no later than 28 April 2023 (the "Tranche"). BNP Paribas Exane will act as principal for the simultaneous on-sale of such shares to the Company and will make its trading decisions concerning the timing of the purchases of the Company's ordinary shares independently of the Company.


The maximum amount allocated to the Tranche (excluding expenses) will be no greater than £50 million (Note 1). The purpose of the Tranche is to reduce the share capital of the Company. As such, the Company will cancel any ordinary shares purchased. This is the third tranche of an overall commitment by the Company to purchase £300 million of its shares for cancellation, as announced on 23 May 2022 (the "Programme").


Any acquisitions under the Programme will be carried out within certain pre-set parameters, and in accordance with the Company's general authority to repurchase shares, the EU Market Abuse Regulation (596/2014) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and Chapter 12 of the Listing Rules. The Company confirms that it currently has no unpublished price sensitive information.


For the avoidance of doubt, no repurchases will be made in respect of the Company's American Depositary Receipts.


BNP Paribas Exane (or any affiliate) may undertake transactions in Ordinary Shares (which may include sales, derivatives, and other hedging activities, in addition to purchases) in order to manage its risk positions arising directly or indirectly from the Programme. Disclosure of any such transactions will not be made by BNP Paribas Exane (or any affiliate) as a result of or as part of the Programme, but BNP Paribas Exane (or any affiliate) will make any disclosures they are legally required to make in relation to such transactions.


Note 1. The maximum number of shares that the Company may purchase would be 172,923,195 ordinary shares of 15 5/7 pence each, in line with the authority granted to Kingfisher by shareholders at the Company's Annual General Meeting on 22 June 2022 and taking in to account the 31,306,331 shares purchased and cancelled during the previous tranche completed on 29 September 2022.






Company Secretary

+44 (0) 77 6880 6248

Investor Relations

+44 (0) 20 7644 1082


+44 (0) 20 7644 1170




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.